The following IPOs are expected to price this week:
Aquinox Pharmaceuticals (AQXP), a clinical-stage biotech developing novel drug candidates to treat inflammation and cancer, plans to raise $41 million by offering 3.7 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Aquinox Pharmaceuticals would command a market value of $107 million. Aquinox Pharmaceuticals was founded in 2003. The Vancouver, Canada-based company plans to list on the NASDAQ under the symbol AQXP. Jefferies & Co. and Cowen & Company are the joint bookrunners on the deal.
Coupons.com (COUP), which distributes digital coupons for consumer packaged good companies, plans to raise $130 million by offering 10.0 million shares at a price range of $12.00 to $14.00. At the midpoint of the proposed range, Coupons.com would command a market value of $1.1 billion. Coupons.com, which was founded in 1998, booked $168 million in sales over the last 12 months. The Mountain View, CA-based company plans to list on the NYSE under the symbol COUP. Goldman Sachs, Allen & Company, BofA Merrill Lynch and RBC Capital Markets are the joint bookrunners on the deal.
Recro Pharma (REPH), a clinical-stage biotech developing non-opioid therapeutics for the treatment of pain, plans to raise $28 million by offering 2.5 million shares at a price range of $10.00 to $12.00. At the midpoint of the proposed range, Recro Pharma would command a market value of $61 million. Recro Pharma, which was founded in 2008, booked $0 million in sales over the last 12 months. The Malvern, PA-based company plans to list on the NASDAQ under the symbol REPH. Aegis Capital is the lead bookrunner on the deal.
Renaissance Capital will have Pre-IPO Research available on each of these upcoming IPOs prior to its pricing.
Last week, there were 2 IPO pricings. Varonis Systems (VRNS), which provides software that manages human-generated unstructured data, was the week's winner, ending up 100% from its IPO price.
